Veritas Capital-backed Verscend Technologies, a software company, completed the acquisition of Cotiviti Holdings, a solutions and analytics company, for $4.9bn. “A core tenet of Veritas’ investment philosophy is identifying organizations that are positioned to have transformational impact in their respective domains. We see the combination of Cotiviti and Verscend as bringing much needed precision and insight to the healthcare system. We expect that the two companies’ complementary data sets, analytical capabilities, and industry expertise will accelerate forward momentum for the new Cotiviti through smarter, faster solutions that address rising costs, eliminate waste, and speed quality improvement for the healthcare industry overall,” Ramzi Musallam, Veritas Capital, CEO and Managing Partner.